In addition, knocking down FDX1 expression has been found to increase mitochondrial membrane potential loss and lipid peroxidation in ovarian cancer cells treated with cisplatin, thereby enhancing ferroptosis and increasing cisplatin sensitivity. The gene discussed is FDX1; the disease is ovarian carcinoma.